AMICUS THERAPEUTICS, INC. Business Finance Contracts & Agreements
46 Contracts & Agreements
- Credit Agreements (2 contracts)
- Equity Distribution Agreements (1)
- Exchange Agreements (1)
- Indenture Agreements (1)
- Investor Rights Agreements (2)
- Note Agreements (10)
- Purchase Agreements (2)
- Stock Agreements (10)
- Underwriting Agreements (7)
- Warrant Agreements (10)
- Equity Distribution Agreement, dated November 7, 2022, by and between Amicus Therapeutics, Inc. and Goldman Sachs & Co. LLC (Filed With SEC on November 7, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on September 29, 2021)
- Form of Exchange Agreement Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on June 19, 2019)
- Underwriting Agreement, dated May 30, 2019, by and among Amicus Therapeutics, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and SVB Leerink LLC (Filed With SEC on May 31, 2019)
- Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on May 22, 2019)
- Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on March 13, 2019)
- Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on February 8, 2019)
- Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023 (Filed With SEC on January 24, 2019)
- Underwriting Agreement dated February 15, 2018, by and among Amicus Therapeutics, Inc., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several... (Filed With SEC on February 16, 2018)
- Amended and Restated Amicus Therapeutics, Inc. Restricted Stock Unit Deferral Plan (Filed With SEC on December 28, 2017)
- AMICUS THERAPEUTICS, INC. 18,367,347 Shares of Common Stock, Par Value $0.01 per Share Underwriting Agreement (Filed With SEC on July 13, 2017)
- NOTE PURCHASE AGREEMENT (Filed With SEC on December 21, 2016)
- NOTE PURCHASE AGREEMENT (Filed With SEC on December 21, 2016)
- NOTE PURCHASE AGREEMENT (Filed With SEC on December 21, 2016)
- NOTE PURCHASE AGREEMENT (Filed With SEC on December 21, 2016)
- NOTE PURCHASE AGREEMENT (Filed With SEC on December 21, 2016)
- NOTE PURCHASE AGREEMENT (Filed With SEC on December 21, 2016)
- AMICUS THERAPEUTICS, INC. (Company) WILMINGTON TRUST, NATIONAL ASSOCIATION (Trustee) 3.00% Convertible Senior Notes due 2023 INDENTURE Dated as of December 21, 2016 (Filed With SEC on December 21, 2016)
- JOINDER TO AND AMENDMENT OF NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on July 1, 2016)
- FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on July 1, 2016)
- AMICUS THERAPEUTICS, INC. $100,000,000 OF SHARES COMMON STOCK (PAR VALUE $0.01 PER SHARE) SALES AGREEMENT (Filed With SEC on February 26, 2016)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on February 22, 2016)
- Exhibit C FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 22, 2016)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on October 1, 2015)
- FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 1, 2015)
- AMICUS THERAPEUTICS, INC. 16,981,132 Shares of Common Stock, Par Value $0.01 per Share Underwriting Agreement (Filed With SEC on June 12, 2015)
- FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT (Filed With SEC on April 28, 2015)
- AMICUS THERAPEUTICS, INC. 13,850,000 Shares of Common Stock, Par Value $0.01 Per Share Underwriting Agreement (Filed With SEC on November 24, 2014)
- AMICUS THERAPEUTICS, INC. RESTRICTED STOCK UNIT DEFERRAL PLAN (Filed With SEC on April 10, 2014)
- AMICUS THERAPEUTICS, INC. $40,000,000 OF SHARES COMMON STOCK (PAR VALUE $0.01 PER SHARE) SALES AGREEMENT (Filed With SEC on March 4, 2014)
- Schedule A Stock Options Expiration Schedule (Filed With SEC on January 8, 2014)
- Credit and Security Agreement CREDIT AND SECURITY AGREEMENT (Filed With SEC on December 30, 2013)
- FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on November 21, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 21, 2013)
- AMICUS THERAPEUTICS, INC. (a Delaware corporation) 10,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 2, 2012)
- Form of Warrant to Purchase Common Stock AMICUS THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK To Purchase __________________ Shares of Common Stock (Filed With SEC on February 26, 2010)
- EX-10.24: 2007 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 17, 2007)
- EX-4.1: SPECIMEN STOCK CERTIFICATE (Filed With SEC on May 17, 2007)
- EX-1.1: FORM OF UNDERWRITING AGREEMENT (Filed With SEC on May 17, 2007)
- EX-10.21: RESTRICTED STOCK AGREEMENT (Filed With SEC on April 27, 2007)
